Re-Vana Therapeutics raises $11.9m to boost eye disease treatment
Re-Vana Therapeutics is developing technology that can provide sustained drug delivery for up to six months for people with eye diseases.
Stay updated with breaking news from Robert Avery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Re-Vana Therapeutics is developing technology that can provide sustained drug delivery for up to six months for people with eye diseases.
/PRNewswire/ -- Re-Vana Therapeutics Ltd, a privately-held specialty drug delivery company developing sustained-release therapeutics for the treatment of...
/PRNewswire/ -- Re-Vana Therapeutics Ltd, a privately-held specialty drug delivery company developing sustained-release therapeutics for the treatment of...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
The Gilbert Family Foundation in Detroit has announced $23 million in grants to fund research in vision restoration and brain tumors.